Libramed Pharmaceuticals Private Limited, a active private limited company, was established on 01 May 2019 in Hyd, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U52599TG2019PTC132443. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.50 M.
Employing 27 professional, Its leadership includes Mahendhar Punnam (Director), Bharath Gajula (Director), Latha Sri Bura (Director). Past directors included Naresh Babu Gundluru, Shailaja Cheruku, Jagan Rao Gandra. It holds ₹7.61 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 13-198/16/Klr/2/96 & 97/E, Njr & Klr Nagar ,Phase 2,Block C Road No.1, Hyd, Telangana, 501401.
U52599TG2019PTC132443
132443
01 May 2019
₹2.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Libramed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahendhar Punnam | Director | 01 May 2019 | Current |
| Bharath Gajula | Director | 21 Oct 2022 | Current |
| Latha Sri Bura | Director | 21 Oct 2022 | Current |
| Pannala Mahipal Reddy | Director | 26 Jul 2019 | Current |
| Balakrishna Dyavanapelly | Director | 01 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Oct 2024 | Past |
| Pramod Abcsdd | Director | 07 Jan 2023 | Past |
| Pramod Abcsdd | Managing Director | 06 Sep 2022 | Past |
| Pramod Abcsdd | Director | 06 Apr 2020 | Past |
| Pramod Abcsdd | Director | 28 Oct 2024 | Past |
| Pramod Abcsdd | Director | 06 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Libramed Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.83% increase. The company also saw a substantial improvement in profitability, with a 35.12% increase in profit. The company's net worth Soared by an impressive increase of 58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Libramed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,613,324.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2023 | Others | ₹7.61 M | Open |
Explore comprehensive loan charge details -
Libramed Pharmaceuticals has a workforce of 27 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Libramed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Libramed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Libramed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Libramed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on A charge with Others amounted to Rs. 7.61 M with Charge ID 100848219 was registered on 28 Dec 2023. was documented.
The activity Bharath Gajula was appointed as a Director was appointed as a Director on 21 Oct 2022 & has been associated with this company since 3 years 2 months . was completed.
Progress on Latha Sri Bura was appointed as a Director was appointed as a Director on 21 Oct 2022 & has been associated with this company since 3 years 2 months . was documented.
Pannala Mahipal Reddy was appointed as a Director was appointed as a Director on 26 Jul 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
The CIN of Libramed Pharmaceuticals Private Limited is U52599TG2019PTC132443.
Libramed Pharmaceuticals Private Limited is headquartered at 13-198/16/Klr/2/96 & 97/E, Njr & Klr Nagar ,Phase 2,Block C Road No.1, Hyd, Telangana, 501401.
Libramed Pharmaceuticals Private Limited was incorporated on 01 May 2019.
The current directors of Libramed Pharmaceuticals Private Limited are
The primary industry of Libramed Pharmaceuticals Private Limited is Trade.
Libramed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Libramed Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX